参考文献/References:
[1]Shen WF,Tribouilloy C,Mirode A,et al. Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease[J] . Eur Heart J,1992,13(1):39-44.
[2]Yang H,Zhang FF,Peng XH,et al. Efficacy of medication directed by home-monitoring cardiac resynchronization therapy in chronic heart failure patients[J]. Chin Med Sci J,2014,29(1):61-62.
[3]贾政,魏玲,刘茜,等.重组腺病毒介导Klotho基因转导对大鼠心力衰竭心肌重构的影响[J]. 中华心血管病杂志,2015,43(3):219-226.
[4]Ross GR,Bajwa T,Edwards S,et al. Enhanced store-operated Ca2+ influx and ORAI1 expression in ventricular fibroblasts from human failing heart[J]. Biol Open ,2017,6(3):326-332.
[5]DeAguero JL,McKown EN,Zhang L,et al. Altered protein levels in the isolated extracellular matrix of failing human hearts with dilated cardiomyopathy[J]. Cardiovasc Pathol,2017,26:12-20.
[6]Yue L,Xie J,Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation[J]. Cardiovasc Res,2011,89(4):744-753.
[7]Michela P,Velia V,Aldo P,et al. Role of connexin 43 in cardiovascular diseases[J]. Eur J Pharmacol,2015,768:71-76.
[8]Nikolaidou T,Cai XJ,Stephenson RS,et al. Congestive heart failure leads to prolongation of the PR interval and atrioventricular junction enlargement and ion channel remodelling in the rabbit[J]. PLoS One,2015,10(10):e0141452.
[9]Greener ID,Sasano T,Wan X,et al. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction[J]. J Am Coll Cardiol,2012,60(12):1103-1110.
[10]Mayama T,Matsumura K,Lin H,et al. Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis[J]. Exp Clin Cardiol,2007,12(2):67-76.
[11]Ai X,Pogwizd SM. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A[J]. Circ Res,2005,96(1):54-63.
[12]Imanaga I. Pathological remodeling of cardiac gap junction connexin 43-With special reference to arrhythmogenesis[J]. Pathophysiology,2010,17(2):73-81.
[13]Travers JG,Kamal FA,Valiente-Alandi I,et al. Pharmacological and activated fibroblast targeting of Gβγ-GRK2 after myocardial ischemia attenuates heart failure progression[J]. J Am Coll Cardiol,2017,70(8):958-971.
[14]Dhein S,Hagen A,Jozwiak J,et al. Improving cardiac gap junction communication as a new antiarrhythmic mechanism:the action of antiarrhythmic peptides[J]. Naunyn Schmiedebergs Arch Pharmacol,2010,381(3):221-234.
[15]马金,陈秋雄,吕渭辉. 神经重构在心肌梗死后心律失常中的作用及机制[J].心血管病学进展,2019,40(2):260-263.
[16]Luo D,Hu H,Qin Z,et al. Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction[J]. Auton Neurosci ,2017,208:73-79.
[17]Chen RH,Li YG,Jiao KL,et al. Overexpression of Sema3a in myocardial infarction border zone decreases vulnerability of ventricular tachycardia post-myocardial infarction in rats[J]. J Cell Mol Med,2013,17(5):608-616.
[18]Swissa M,Zhou S,Gonzalez-Gomez I,et al. Long-term subthreshold electrical stimulation of the left stellate ganglion and a canine model of sudden cardiac death[J]. J Am Coll Cardiol,2004,43(5):858-864.
[19]Wang Y,Tan J,Yin J,et al. Targeting blockade of nuclear factor-κB in the hypothalamus paraventricular nucleus to prevent cardiac sympathetic hyperinnervation post myocardial infarction[J]. Neurosci Lett,2019,707:134319.
[20]Hu J,Huang CX,Rao PP,et al. Inhibition of microRNA-155 attenuates sympathetic neural remodeling following myocardial infarction via reducing M1 macrophage polarization and inflammatory responses in mice[J]. Eur J Pharmacol,2019,851:122-132.
[21]Shi Y,Yin J,Hu H,et al. Targeted regulation of sympathetic activity in paraventricular nucleus reduces inducible ventricular arrhythmias in rats after myocardial infarction[J]. J Cardiol,2019,73(1):81-88.
[22]Arslan F,Bongartz L,Ten BJM,et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:comments from the Dutch ACS working group[J]. Neth Heart J,2018,26(9):417-421.
[23]Song W,Wang H,Wu Q. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)[J]. Gene,2015,569(1):1-6.
[24]Jatene AD.Left ventricular aneurysmectomy. Resection or reconstruction[J]. J Thorac Cardiovasc Surg,1985,89(3):321-331.
[25]B?aszyk K,Wa?niewski M,Grajek S.Contribution of atrioventricular node inputs on orthodromic atrioventricular reentrant tachycardia cycle length[J]. Kardiol Pol,2010,68(2):232-236.
[26]Sartipy U,Albage A,Straat E,et al. Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure[J]. Ann Thorac Surg,2006,81(1):65-71.
[27]Hashimoto K,Watanabe I,Okumura Y,et al. Comparison of endocardial and epicardial lesion size following large-tip and extra-large-tip transcatheter cryoablation[J]. Circ J,2009,73(9):1619-1626.
[28]Boukens BJ,Christoffels VM,Coronel R,et al. Developmental basis for electrophysiological heterogeneity in the ventricular and outflow tract myocardium as a substrate for life-threatening ventricular arrhythmias[J]. Circ Res,2009,104(1):19-31.
[29]Izquierdo M,Sánchez-Gómez JM, Ferrero de Loma-Osorio A,et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease[J]. Circ Arrhythm Electrophysiol,2015,8(4):882-829.
[30]Yang H,Zhang FF,Peng XH,et al. Efficacy of medication directed by home-monitoring cardiac resynchronization therapy in chronic heart failure patients[J].Chin Med Sci J,2014,29(1):61-62.
[31]Izquierdo M,Sánchez-Gómez JM, Ferrero de Loma-Osorio A,et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease[J]. Circ Arrhythm Electrophysiol,2015,8(4):882-889.
[32]Yu Y,Gao MX,Wang C,et al. Bipolar radiofrequency ablation for left ventricular aneurysm-related ventricular arrhythmia[J]. J Thorac Cardiovasc Surg,2012,144(4):e101-e102.
[33]戴龙圣,刘长城,高铭鑫,等. CARTO标测下行双极射频消融治疗左室室壁瘤合并室性心律失常的随机对照试验[J]. 中国胸心血管外科临床杂志,2017，24(9):27-32.
[34]Stevenson WG,Tedrow UB,Reddy V,et al. Infusion needle radiofrequency ablation for treatment of refractory ventricular arrhythmias[J]. J Am Coll Cardiol,2019,73(12):1413-1425.
相似文献/References:
[1]张耀庭 李烽 朱永翔 陆丽洁 龙明智.沙库巴曲/缬沙坦在室性心律失常中的研究进展[J].心血管病学进展,2019,(7):982.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.004]
ZHANG Yaoting,LI Feng,ZHU Yongxiang,et al.Research Progress of Sacubitril/Valsartan in Ventricular Arrhythmia[J].Advances in Cardiovascular Diseases,2019,(1):982.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.004]
[2]梁砚薷李晶洁.神经元型钠通道在室性心律失常发生机制中的作用[J].心血管病学进展,2020,(1):43.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.012]
LIANG Yanru,LI Jingjie.Role of Neuronal Sodium Channels in Development of Ventricular Arrhythmias[J].Advances in Cardiovascular Diseases,2020,(1):43.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.012]
[3]罗功名 彭瑜 张钲.碎裂QRS波群对急性心肌梗死的诊断和预后预测价值的研究进展[J].心血管病学进展,2020,(6):579.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.005]
LUO GongmingPENG YuZHANG Zheng.Fragmented QRS Complex in the Diagnostic and Prognosis Value of Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):579.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.005]
[4]赵若寒 罗素新 熊峰 李袁静 黄龙祥.心力衰竭并发复杂性室性心律失常相关因素分析[J].心血管病学进展,2020,(7):782.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.025]
ZHAO Ruohan,LUO Suxin,XIONG Feng,et al.Analysis of Related Factors of Heart Failure Accompany?span style="">with Complex Ventricular Arrythmia[J].Advances in Cardiovascular Diseases,2020,(1):782.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.025]
[5]杨超,文颐 崔凯军.左室穹顶部起源室性心律失常消融治疗进展[J].心血管病学进展,2021,(2):106.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.003]
YANG ChaoWEN YiCUI Kaijun.Ablation of Ventricular Arrhythmia Originating from Left Ventricular Summit[J].Advances in Cardiovascular Diseases,2021,(1):106.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.003]
[6]王思博 王连生.心肌梗死后室性心律失常的治疗进展[J].心血管病学进展,2021,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]
WANG SiboWANG Liansheng.Treatment of Ventricular Arrhythmias after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(1):481.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.001]
[7]董震宇 商鲁翔 汤宝鹏.立体定向放射治疗在心律失常中的应用进展[J].心血管病学进展,2022,(2):97.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.001]
DONG ZhenyuSHANG LuxiangTANG Baopeng.Application progress of Stereotactic Body Radiation Therapy in Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(1):97.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.001]
[8]王秀秀 熊峰.左心室假腱索的再认识[J].心血管病学进展,2023,(1):67.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.016]
WANG Xiuxiu,XIONG Feng.Re-Recognition of Left Ventricular False Tendon[J].Advances in Cardiovascular Diseases,2023,(1):67.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.016]
[9]素比努尔·吾布力卡斯木 李耀东.肾去交感神经术治疗植入型心律转复除颤器植入术后电风暴的研究进展[J].心血管病学进展,2023,(3):208.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.004]
Subinuer·Wubulikasimu,LI Yaodong.Renal Sympathetic Denervation in Treatment of Electrical Storm After Implantable Cardioverter Defibrillator Implantation[J].Advances in Cardiovascular Diseases,2023,(1):208.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.004]
[10]毕莹莹 杨双 张舒红 唐艳红.P2X3R对心肌梗死大鼠交感神经重构和室性心律失常的影响[J].心血管病学进展,2023,(9):858.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.021]
Bi Yingying,Yang Shuang,Zhang Shuhong,et al.Effect of P2X3R on Sympathetic Remodeling and Ventricular Arrhythmias in Rats with Myocardial Infarction[J].Advances in Cardiovascular Diseases,2023,(1):858.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.021]